C
Crinetics Pharmaceuticals D
D
CRNX
30.750
USD
1.06
(3.57%)
مغلق
حجم التداول
32,515
الربح لكل سهم
-5
العائد الربحي
-
P/E
-8
حجم السوق
2,895,911,816
الأخبار المقالات
العنوان: Crinetics Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.